Skip to main content
SpringerLink
Log in

Non-Curative Radiotherapy for Neurological Cancer

  • Chapter
Cancer: How Worthwhile is Non-Curative Treatment?

Part of the book series: Focus on Cancer ((3292))

  • 37 Accesses

Abstract

Tumours in the central nervous system (CNS) include metastatic disease and primary tumours which range from highly malignant such as high-grade gliomas to curable tumours which include meningiomas, benign pituitary adenomas and cranial germ-cell tumours. Radiotherapy is the mainstay of primary therapy both in the curative and the palliative setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas DGT, McKeran RO (1990) Clinical manifestations of brain tumours. In: Thomas DGT (ed) Neuro-oncology — primary malignant brain tumours. Edward Arnold, London, 141–147.

    Google Scholar 

  2. MacDonald DR, Cascino TL, Schold SCJ, Cairncross G (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280.

    PubMed  CAS  Google Scholar 

  3. Brazil LC, Thomas R, Laing R et al. (1997) Verbally administered Barthel Index as functional assessment in brain tumour patients. J Neuro-oncol 34, 187–192.

    Article  CAS  Google Scholar 

  4. Grant R, Slattery J, Gregor A, Whittle IR (1994) Recording neurological impairment in clinical trials of glioma. J Neuro-oncol 19:37–49.

    Article  CAS  Google Scholar 

  5. Osoba D, Aaronson NK, Muller M et al. (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139–150.

    Article  PubMed  CAS  Google Scholar 

  6. Kristiansen K, Hagen S, Kollevold T et al. (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649–652.

    Article  PubMed  CAS  Google Scholar 

  7. Walker MD, Alexander E, Hunt WE et al. (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343.

    Article  PubMed  CAS  Google Scholar 

  8. Bleehen NM, Stenning SP and on behalf of the Medical Research Council Brain Tumour Working Party (1991) A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769–774.

    Article  PubMed  CAS  Google Scholar 

  9. Chang CH, Horton J, Schoenfeld D et al. (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997–1007.

    Article  PubMed  CAS  Google Scholar 

  10. Brada M, Laing R (1994) Radiosurgery/stereotactic external beam radiotherapy for malignant brain tumours: the Royal Marsden experience. In: Wiestier OD, Schlegel U, Schramm J (eds) Molecular neuro-oncology and its impact on the clinical management of brain tumours. Springer-Verlag, Berlin, pp 91–103.

    Google Scholar 

  11. Sneed PK, Larson DA, Gutin PH (1994) Brachytherapy and hyperthermia for malignant astrocytomas. Semin Oncol 21:186–197.

    PubMed  CAS  Google Scholar 

  12. Loeffler J, Alexander E III. (1991) Stereotactic radiosurgery for malignant gliomas. Second International Neuro-oncology Conference, London.

    Google Scholar 

  13. Curran WJ, Scott CB, Weinstein AS et al. (1993) Survival comparison of radiosurgery-eligible and-ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11:857–862.

    PubMed  Google Scholar 

  14. Curran WJ, Scott CB, Horton J et al. (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704–710.

    Article  PubMed  Google Scholar 

  15. MRC Brain Tumour Working Party (1990) Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neuro-oncol 9:47–55.

    Article  Google Scholar 

  16. Brada M (1995) Central nervous system tumours. In: Horwich A (ed) Oncology — a multidisciplinary textbook. Chapman and Hall, London, pp 395–416.

    Google Scholar 

  17. Bauman GS, Gaspar LE, Fisher BJ et al. (1994) A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29:835–839.

    Article  PubMed  CAS  Google Scholar 

  18. Thomas R, James N, Guerrero D et al. (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33:113–116.

    Article  PubMed  CAS  Google Scholar 

  19. Rajan B, Ross GM, Lim CC et al. (1994) Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer 30A:1809–1815.

    Article  PubMed  CAS  Google Scholar 

  20. Moser RP (1988) Surgery for glioma relapse: factors that influence a favourable outcome. Cancer 62:381–390.

    Article  PubMed  CAS  Google Scholar 

  21. Leibel SA, Gutin PH, Wara WM et al. (1989) Survival and quality of life after interstitial implantation of removable high-activity Iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17:1129–1139.

    Article  PubMed  CAS  Google Scholar 

  22. Laing RW, Warrington AP, Graham J et al. (1993) Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother Oncol 27:22–39.

    Article  PubMed  CAS  Google Scholar 

  23. Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583–590.

    Article  PubMed  CAS  Google Scholar 

  24. Shaw EG, Daumas-Duport C, Scheithauer BW et al. (1989) Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70:853–861.

    Article  PubMed  CAS  Google Scholar 

  25. Rajan B, Pickuth D, Ashley S et al. (1994) The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiat Oncol Biol Phys 28:405–413.

    Article  PubMed  CAS  Google Scholar 

  26. Ostertag C, Warnke P (1991) Interstitial radiotherapy for brain tumours. Br J Neurosurg 5:421–436.

    Article  Google Scholar 

  27. Diener-West M, Dobbins TW, Phillips TL, Nelson DF (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16:669–673.

    Article  PubMed  CAS  Google Scholar 

  28. Borgelt B, Gelber R, Kramer S et al. (1980) The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6:1–9.

    PubMed  CAS  Google Scholar 

  29. Haie-Meder C, Pallae-Cosset B, Laplanche A et al. (1993) Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 26:111–116.

    Article  PubMed  CAS  Google Scholar 

  30. Patchell R, Tibbs P, Walsh J et al. (1990) A randomised trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500.

    Article  PubMed  CAS  Google Scholar 

  31. Smalley SR, Laws ER, OcTallon JR, Shaw EG, Schray MF (1992) Resection for solitary brain metastases. J Neurosurg 77:531–540.

    Article  PubMed  CAS  Google Scholar 

  32. Noordijk EM, Vecht CJ, Haaxma-Reiche H et al. (1994) The choice of treatment of single brain metastasis should be based on extracranial tumour activity and age. Int J Radiat Oncol Biol Phys 29:711–717.

    Article  PubMed  CAS  Google Scholar 

  33. Engenhart R, Kimmig BN, Hover KH et al. (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:1353–1361.

    Article  PubMed  CAS  Google Scholar 

  34. Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327:614–619.

    Article  PubMed  CAS  Google Scholar 

  35. Helweg-Larsen S, Sorensen PS (1994) Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer 3:396–398.

    Article  Google Scholar 

  36. Kato AM Ushio Y, Hayakawa T et al. (1985) Circulatory disturbance of the spinal cord with epidural neoplasm in rats. J Neurosurg 63:260–265.

    Article  PubMed  CAS  Google Scholar 

  37. Sorensen PS, Helweg-Larsen S, Mouridsen H, Hansen HH (1994) Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1:22–27.

    Article  Google Scholar 

  38. Gilbert RW, Kim J-H and Posner JB (1978) Epidural spinal cord compression from metastatic tumour: diagnosis and treatment. Ann Neurol 3:40–51.

    Article  PubMed  CAS  Google Scholar 

  39. Hill ME, Richards MA, Gregory WM, Smith P, Rubens RD (1993) Spinal cord compression in breast cancer: a review of 70 cases. Br J Cancer 68:969–973.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Barton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Brazil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Brada
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE, UK

    Maurice L. Slevin MB, ChB, MD, FRCP  & Teresa Tate FRCP, FRCR  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag London Limited

About this chapter

Cite this chapter

Barton, R., Brazil, L., Brada, M. (1998). Non-Curative Radiotherapy for Neurological Cancer. In: Slevin, M.L., Tate, T. (eds) Cancer: How Worthwhile is Non-Curative Treatment?. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-1509-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1509-0_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-76083-2

  • Online ISBN: 978-1-4471-1509-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation